Zobrazeno 1 - 10
of 169
pro vyhledávání: ''
Publikováno v:
Leuk Lymphoma
Relapsed/refractory Primary Central Nervous System Lymphoma (R/R PCNSL) has a poor prognosis with no established preferred treatment. We report the efficacy and toxicity of a combination chemotherapy regimen: methotrexate, carmustine, etoposide, and
Publikováno v:
Cancer Investigation. 40:124-131
BACKGROUND Large Cell Neuroendocrine Carcinoma of the Lung (L-LCNEC) is a rare type of neuroendocrine lung cancer that is increasingly diagnosed. However, the optimal management regarding the advanced stage is unclear. The purpose of this article is
Autor:
David Dingli, Eli Muchtar, Taxiarchis Kourelis, Alissa Visram, Abdullah S. Al Saleh, Ronald S. Go, Martha Q. Lacy, Francis K. Buadi, Shaji Kumar, Harsh Parmar, Prashant Kapoor, S. Vincent Rajkumar, Morie A. Gertz, Robert A. Kyle, Rahma Warsame, Suzanne R. Hayman, Nelson Leung, Angela Dispenzieri, Wilson I. Gonsalves
Publikováno v:
Leukemia & Lymphoma. 62:3011-3018
This is a retrospective study of patients with multiple myeloma (MM) who were >75 years old. We identified 394 patients and for non-trial patients (n = 350), immunomodulatory drug (IMiD)+dex (32%) was the most commonly used regimen followed by alkyla
Autor:
Sho Miyamoto, Shinichiro Kina, Hajime Sunakawa, Takao Kinjo, Reika Kawabata-Iwakawa, Akira Arasaki
Publikováno v:
Journal of Drug Targeting. 29:1118-1127
Well-differentiated head and neck squamous cell carcinoma (HNSCC), accounts for approximately 10% of all HNSCCs and, while these cases are associated with good prognosis after surgery, these are resistant to chemotherapy. Here we designed a retrospec
Autor:
Shin Ohara, Shiro Ide, Yasuo Nishigami, Masao Hagihara, Mitsuo Mita, Keisuke Takabatake, Tomiyuki Sugi, Morihiro Inoue, Homare Hanai, Tomoyuki Uchida, Hirohisa Saigo
Publikováno v:
Leukemia & Lymphoma. 62:1405-1410
The aim of the present study was to identify the risk factors for lenalidomide (Len)-associated skin rash. We retrospectively investigated the medical records of 144 multiple myeloma patients treated with Len-containing therapies. A total of 64 of 14
Autor:
Benny Johnson, Shahab U. Ahmed, Jennifer L. Guerra, Jane E. Rogers, Alexandre A. Jácome, Aki Ohinata, Amir Mehdizadeh, Robert A. Wolff, Van K. Morris, Nicole D. Rothschild, Cathy Eng
Publikováno v:
Expert Review of Anticancer Therapy. 20:901-908
Metastatic squamous cell carcinoma anal cancer (SCCA) is rare. Prospective data recommends front-line platinum doublet combinations and second-line anti-programmed death-1 therapy. Standard therapy beyond these treatments are currently unknown. We ev
Autor:
Xiaomei Ma, Jan Philipp Bewersdorf, Amy J. Davidoff, Steven D. Gore, Nikolai A. Podoltsev, Rong Wang, Scott F. Huntington, Xin Hu, Amer M. Zeidan
Publikováno v:
Leuk Lymphoma
Hypomethylating agents (HMA) showed overall survival (OS) benefits in patients with higher-risk myelodysplastic syndromes (HR-MDS) in clinical trials. We conducted a retrospective cohort study of Surveillance, Epidemiology, and End Results (SEER)-Med
Autor:
Filippo Antonio Canale, Maurizio Miglino, Lorenzo Manconi, Marco Gobbi, Paola Minetto, Michele Cea, Livia Giannoni, Fabio Guolo, Elisa Coviello, Filippo Ballerini, Riccardo Marcolin, Marino Clavio, Roberto M. Lemoli, Antonia Cagnetta
Publikováno v:
Leukemia & Lymphoma. 61:84-90
Cisplatin-containing salvage regimens followed by autologous hematopoietic stem cell (HSC) transplantation are the current standard of care for relapsed or refractory (R/R) lymphomas. We retrospectively analyzed efficacy and stem cell mobilizing acti
Autor:
Michael W. Cullen, Mrinal M. Patnaik, Meagan Grove, Amanda G. Sierzchulski, Kristin C. Mara, Jason N. Barreto, Ross A. Dierkhising, Nathan J. Dahl, Pritish K. Tosh, Michael J. Ackerman
Publikováno v:
Leukemia & Lymphoma. 60:3512-3520
Benefits of serial electrocardiographic (ECG) monitoring to detect QT prolongation in patients with hematological malignancies remain unclear. This retrospective, single-center, study evaluated 316 adult acute leukemia and high-risk MDS patients who
Autor:
Makoto Onizuka, Kazuteru Ohashi, Yoshiko Atsuta, Tadakazu Kondo, Shinichi Kako, Junji Tanaka, Kaito Harada, Jun Ishikawa, Yukiyasu Ozawa, Kazunori Imada, Tomoaki Fujisaki, Takayoshi Tachibana, Takahiro Fukuda, Masashi Sawa
Publikováno v:
Leukemia & Lymphoma. 60:3521-3528
To evaluate the prognostic impact of melphalan dose and total body irradiation (TBI) in acute lymphoblastic leukemia (ALL) patients undergoing reduced-intensity allogeneic transplantation, we retrospectively compared the outcomes between higher-dose